Astragalus polysaccharide improve the proliferation and insulin secretion of mouse pancreatic β cells induced by high glucose and palmitic acid partially through promoting miR-136-5p and miR-149-5p expression

References

• Singh R, Chandel S, Dey D, et al. Epigenetic modification and therapeutic targets of diabetes mellitus. Biosci Rep. 2020;40(9):20202160. BSR.
   Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81–90.
   PubMedGoogle Scholar
• Boland BB, Cj R, Js G. The dynamic plasticity of insulin production in β-cells. Mol Metab. 2017;6(9):958–973.
   PubMed Web of Science ®Google Scholar
• Lin JS, Dong HL, Chen GD, et al. Erythrocyte saturated fatty acids and incident type 2 diabetes in Chinese men and women: a prospective cohort study. Nutrients. 2018;10(10):1393.
   PubMed Web of Science ®Google Scholar
• Lu H, Hao L, Li S, et al. Elevated circulating stearic acid leads to a major lipotoxic effect on mouse pancreatic beta cells in hyperlipidaemia via a miR-34a-5p-mediated PERK/p53-dependent pathway. Diabetologia. 2016;59(6):1247–1257.
   PubMed Web of Science ®Google Scholar
• Ruan D, Liu Y, Wang X, et al. miR-149-5p protects against high glucose-induced pancreatic beta cell apoptosis via targeting the BH3-only protein BIM. Exp Mol Pathol. 2019;110:104279.
   PubMed Web of Science ®Google Scholar
• Blahova J, Martiniakova M, Babikova M, et al. Pharmaceutical drugs and natural therapeutic products for the treatment of type 2 diabetes mellitus. Pharmaceuticals (Basel). 2021;14(8):806.
   PubMedGoogle Scholar
• Wang PC, Zhao S, Yang BY, et al. Anti-diabetic polysaccharides from natural sources: a review. Carbohydr Polym. 2016;148:86–97.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ren W, Zhang L, et al. A review of the pharmacological action of astragalus polysaccharide. Front Pharmacol. 2020;11:349.
   PubMed Web of Science ®Google Scholar
• Guo Z, Lou Y, Kong M, et al. A systematic review of phytochemistry, pharmacology and pharmacokinetics on astragali radix: implications for astragali radix as a personalized medicine. Int J Mol Sci. 2019;20(6):1463.
   Web of Science ®Google Scholar
• Zhang Z, Zhang L, Xu H. Effect of Astragalus polysaccharide in treatment of diabetes mellitus: a narrative review. J Tradit Chin Med. 2019;39:133–138.
   PubMed Web of Science ®Google Scholar
• Cazzanelli P, Wuertz-Kozak K. MicroRNAs in intervertebral disc degeneration, apoptosis, inflammation, and mechanobiology. Int J Mol Sci. 2020;21(10):3601.
   PubMed Web of Science ®Google Scholar
• Naqvi RA, Gupta M, George A, et al. MicroRNAs in shaping the resolution phase of inflammation. Semin Cell Dev Biol. 2021. DOI:10.1016/j.semcdb.2021.03.019
   Web of Science ®Google Scholar
• Rajkumar KV, Lakshmanan G, Sekar D. Identification of miR-802-5p and its involvement in type 2 diabetes mellitus. World J Diabetes. 2020;11(12):567–571.
   PubMed Web of Science ®Google Scholar
• Song Z, Ma J, Lu Y, et al. The protective role of the MKP-5-JNK/P38 pathway in glucolipotoxicity-induced islet β-cell dysfunction and apoptosis. Exp Cell Res. 2019;382(1):111467.
   PubMed Web of Science ®Google Scholar
• Jiang H, Li Y, Li J, et al. Long noncoding RNA LSINCT5 promotes endometrial carcinoma cell proliferation, cycle, and invasion by promoting the Wnt/β-catenin signaling pathway via HMGA2. Ther Adv Med Oncol. 2019;11:1758835919874649.
   Web of Science ®Google Scholar
• Syed I, Mf RDC, Jf M, et al. PAHSAs attenuate immune responses and promote β cell survival in autoimmune diabetic mice. J Clin Invest. 2019;129(9):3717–3731.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–97.
   PubMed Web of Science ®Google Scholar
• Marselli L, Thorne J, Dahiya S, et al. Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS One. 2010;5(7):e11499.
   PubMed Web of Science ®Google Scholar
• Pavlikova N, Sramek J, Jelinek M, et al. Markers of acute toxicity of DDT exposure in pancreatic beta-cells determined by a proteomic approach. PLoS One. 2020;15(10):e0229430.
   PubMed Web of Science ®Google Scholar
• Kameswaran V, Bramswig NC, McKenna LB, et al. Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab. 2014;19(1):135–145.
   PubMed Web of Science ®Google Scholar
• Vetere A, Choudhary A, Sm B, et al. Targeting the pancreatic β-cell to treat diabetes. Nat Rev Drug Discov. 2014;13(4):278–289.
   PubMed Web of Science ®Google Scholar
• Fujitani Y. Transcriptional regulation of pancreas development and β-cell function [Review]. Endocr J. 2017;64(5):477–486.
   PubMed Web of Science ®Google Scholar
• Bhatia P, Raina S, Chugh J, et al. miRNAs: early prognostic biomarkers for Type 2 diabetes mellitus? Biomark Med. 2015;9(10):1025–1040.
   PubMed Web of Science ®Google Scholar
• Esguerra JL, Mollet IG, Salunkhe VA, et al. Regulation of Pancreatic Beta Cell Stimulus-Secretion Coupling by microRNAs. Genes (Basel). 2014;5(4):1018–1031.
   PubMed Web of Science ®Google Scholar
• Jeffery N, Harries LW. miRNAs responsive to the diabetic microenvironment in the human beta cell line EndoC-βH1 may target genes in the FOXO, HIPPO and Lysine degradation pathways. Exp Cell Res. 2019;384(1):111559.
   PubMed Web of Science ®Google Scholar
• Liu L, Pang X, Shang W, et al. miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway. Ren Fail. 2020;42(1):513–522.
   PubMed Web of Science ®Google Scholar
• Grieco FA, Sebastiani G, Juan-Mateu J, et al. MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p regulate the expression of proapoptotic BH3-only proteins DP5 and PUMA in human pancreatic β-Cells. Diabetes. 2017;66(1):100–112.
   PubMed Web of Science ®Google Scholar
• Yuan J, Chen M, Xu Q, et al. Effect of the diabetic environment on the expression of MiRNAs in endothelial cells: mir-149-5p restoration ameliorates the high glucose-induced expression of TNF-α and ER stress markers. Cell Physiol Biochem. 2017;43(1):120–135.
   PubMed Web of Science ®Google Scholar
• Wang W, Feng J, Zhou H, et al. Circ_ 0123996 promotes cell proliferation and fibrosisin mouse mesangial cells through sponging miR-149-5p and inducing Bach1 expression. Gene. 2020;761:144971.
   PubMed Web of Science ®Google Scholar
• Vuadens F, Rufer N, Kress A, et al. Identification of swiprosin 1 in human lymphocytes. Proteomics. 2004;4(8):2216–2220.
   PubMed Web of Science ®Google Scholar
• Avramidou A, Kroczek C, Lang C, et al. The novel adaptor protein Swiprosin-1 enhances BCR signals and contributes to BCR-induced apoptosis. Cell Death Differ. 2007;14(11):1936–1947.
   PubMed Web of Science ®Google Scholar
• Checińska A, Giaccone G, Rodriguez JA, et al. Comparative proteomics analysis of caspase-9-protein complexes in untreated and cytochrome c/dATP stimulated lysates of NSCLC cells. J Proteomics. 2009;72(4):575–585.
   PubMed Web of Science ®Google Scholar
• Wang ZB, Zhang S, Li Y, et al. LY333531, a PKCβ inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1. Acta Pharmacol Sin. 2017;38(7):1009–1023.
   PubMed Web of Science ®Google Scholar
• Wang RM, Wang ZB, Wang Y, et al. Swiprosin-1 promotes mitochondria-dependent apoptosis of glomerular podocytes via P38 MAPK pathway in early-stage diabetic nephropathy. Cell Physiol Biochem. 2018;45(3):899–916.
   PubMedGoogle Scholar